Armenia - inglese - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merck sharp & dohme b.v. waarderweg 39 - rotavirus type g1, rotavirus type g2, rotavirus type g3, rotavirus type g4, rotavirus type p1a - solution oral - not less than 2,2x10^6iu+ not less than 2,8x106iu+ not less than 2,2x10^6iu+ not less than 2x10^6iu+ not less than 2,3x10^6iu

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - corynebacterium diphtheriae crm197 carrier protein aluminium phosphate - solution for injection - 0.5 millilitre

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - diphtheria toxoid tetanus toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin polio virus type 1 inactivated polio virus type 2 inactivated polio virus type 3 inactivated haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid tetanus vaccine adsorbed -

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - pertussis toxoid filamentous haemagglutinin (fha) pertactin diphtheria toxoid tetanus toxoid haemophilus influenzae type b polysaccharide tetanus toxoid - powder for suspension for injection

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - pertussis toxoid filamentous haemagglutinin (fha) pertactin diphtheria toxoid tetanus toxoid haemophilus influenzae type b polysaccharide tetanus toxoid - powder for suspension for injection - %v/v

Malesia - inglese - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - diphtheria toxoid; tetanus toxoid; pertussis toxoid (pt); haemophilus influenza type b conjugate to; pertactin (69 kda outer membrane protein-69k); inactivated polio virus type 3; inactivated polio virus type 2; inactivated polio virus type 1; filamentous haemagglutinin (fha) -

Canada - inglese - Health Canada

glaxosmithkline inc - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliovirus type i; inactivated poliovirus type ii; inactivated poliovirus type iii; haemophilus influenzae type b-prp and tetanus toxoid conjugate (prp-t) - suspension - 25mcg; 25mcg; 8mcg; 30unit; 40unit; 40unit; 8unit; 32unit; 10mcg - pertussis toxoid 25mcg; filamentous haemagglutinin 25mcg; pertactin 8mcg; diphtheria toxoid 30unit; tetanus toxoid 40unit; inactivated poliovirus type i 40unit; inactivated poliovirus type ii 8unit; inactivated poliovirus type iii 32unit; haemophilus influenzae type b-prp and tetanus toxoid conjugate (prp-t) 10mcg - vaccines